Cargando…
Optimization of follow-up in patients with papillary thyroid cancer who show no evidence of disease 9–12 months after treatment
BACKGROUND: Papillary thyroid cancer (PTC) has an excellent prognosis, and recurrence is rare in patients with no evidence of disease (NED) after initial treatment. Despite this, several guidelines recommend long and costly follow-up, with limited evidence of improved patient outcomes. This study ai...
Autores principales: | Nordell, Fabian, Hallal, Ghadir, Asp, Pernilla, Almquist, Martin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8659350/ https://www.ncbi.nlm.nih.gov/pubmed/34882764 http://dx.doi.org/10.1093/bjsopen/zrab119 |
Ejemplares similares
-
Corrigendum to: Optimisation of follow-up in patients with papillary thyroid cancer who show no evidence of disease 9 to 12 months after treatment
por: Nordell, Fabian, et al.
Publicado: (2022) -
CDK9 is up-regulated and associated with prognosis in patients with papillary thyroid carcinoma
por: Guo, Tao, et al.
Publicado: (2022) -
Family caregivers’ assessment of symptoms in persons with dementia using the GBS-scale: differences in rating after psychosocial intervention – an 18-month follow-up study
por: Dahlrup, Beth, et al.
Publicado: (2011) -
Predictive Significance of Serum MMP-9 in Papillary Thyroid Carcinoma
por: Xu, Dahai, et al.
Publicado: (2019) -
Papillary and follicular thyroid carcinomas show a different pattern of ras oncogene mutation.
por: Wright, P. A., et al.
Publicado: (1989)